TERLIVAZ TERLIPRESSIN FOR INJECTION Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for TERLIVAZ TERLIPRESSIN FOR INJECTION with the United States Patent and Trademark Office. The USPTO has given the TERLIVAZ TERLIPRESSIN FOR INJECTION trademark a serial number of 88900093. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by Mallinckrodt Hospital Products IP Limited. The TERLIVAZ TERLIPRESSIN FOR INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hepatorenal syndrome (HRS)
terlivaz terlipressin for injection

General Information

Serial Number88900093
Word MarkTERLIVAZ TERLIPRESSIN FOR INJECTION
Filing DateMonday, May 4, 2020
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7081079
Registration DateTuesday, June 13, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"TERLIPRESSIN FOR INJECTION"
Goods and ServicesPharmaceutical preparations for the treatment of hepatorenal syndrome (HRS)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code005
First Use Anywhere DateWednesday, October 12, 2022
First Use In Commerce DateWednesday, October 12, 2022

Trademark Owner History

Party NameMALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressDUBLIN 15 D15TX2V
IE
Party NameMALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type24 - NOT AVAILABLE
AddressDUBLIN 15 D15TX2V
IE
Party NameMallinckrodt Hospital Products IP Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 15 D15TX2V
IE
Party NameMallinckrodt Hospital Products IP Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 15 D15TX2V
IE

Trademark Events

Event DateEvent Description
Thursday, May 7, 2020NEW APPLICATION ENTERED
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 16, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 29, 2020ASSIGNED TO EXAMINER
Wednesday, August 5, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 5, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, August 5, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 5, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, August 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 19, 2021SOU TEAS EXTENSION RECEIVED
Monday, April 19, 2021SOU EXTENSION 1 FILED
Monday, April 19, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 6, 2021SOU EXTENSION 2 FILED
Wednesday, October 6, 2021SOU EXTENSION 2 GRANTED
Friday, October 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 4, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 4, 2022SOU EXTENSION 3 FILED
Monday, April 4, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2022TEAS STATEMENT OF USE RECEIVED
Monday, November 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 1, 2022USE AMENDMENT FILED
Tuesday, March 21, 2023STATEMENT OF USE PROCESSING COMPLETE
Sunday, May 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

injection terlipressin terlivaz syndrome hepatorenal treatment preparations pharmaceutical